• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

时机至关重要:癌细胞死亡中细胞间变异性的随机起源。

Timing is everything: stochastic origins of cell-to-cell variability in cancer cell death.

机构信息

School of Biological Sciences, University of Auckland, Auckland 1142, New Zealand.

出版信息

Front Biosci (Landmark Ed). 2011 Jan 1;16(1):307-14. doi: 10.2741/3689.

DOI:10.2741/3689
PMID:21196172
Abstract

The diversity of cell populations is regulated by extracellular and intracellular variability. The latter includes genetic, epigenetic and stochastic variability, all contributing to the experimentally observed heterogeneity in response to external death-inducing stimuli. Studies of sources and regulation of variability in commitment to apoptotic cancer cell death are likely to identify the fundamental features of apoptotic protein networks that are responsible for determining the ultimate cell fate. Systems biology approaches, involving computer simulations of the biochemical reactions accompanied, if possible, by experimental verification of selected components of the model, are proving useful in determining the origins of cell-to-cell variability in response to external stress stimuli. Here we summarize our current understanding of the origins of stochastic variability in cells' commitment to apoptosis, and its implications in the field on cancer therapy.

摘要

细胞群体的多样性受到细胞外和细胞内变异性的调节。后者包括遗传、表观遗传和随机变异性,所有这些都导致了对外界诱导死亡刺激的反应的实验观察到的异质性。对凋亡性癌细胞死亡的承诺中变异性的来源和调节的研究,很可能确定负责决定最终细胞命运的凋亡蛋白网络的基本特征。系统生物学方法涉及生化反应的计算机模拟,如果可能的话,还涉及对模型的选定组成部分进行实验验证,这些方法在确定细胞对外界应激刺激的反应中的细胞间变异性的起源方面证明是有用的。在这里,我们总结了我们目前对细胞凋亡承诺中随机变异性的起源的理解,以及它在癌症治疗领域的意义。

相似文献

1
Timing is everything: stochastic origins of cell-to-cell variability in cancer cell death.时机至关重要:癌细胞死亡中细胞间变异性的随机起源。
Front Biosci (Landmark Ed). 2011 Jan 1;16(1):307-14. doi: 10.2741/3689.
2
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability.一种肿瘤异质性的体外模型解析了细胞状态变异性的遗传、表观遗传和随机来源。
PLoS Biol. 2021 Jun 1;19(6):e3000797. doi: 10.1371/journal.pbio.3000797. eCollection 2021 Jun.
3
A minimal model of signaling network elucidates cell-to-cell stochastic variability in apoptosis.信号转导网络的最简模型阐明了细胞凋亡中的细胞间随机变异。
PLoS One. 2010 Aug 11;5(8):e11930. doi: 10.1371/journal.pone.0011930.
4
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
5
Cell-to-cell variability in cell death: can systems biology help us make sense of it all?细胞死亡中的细胞间变异性:系统生物学能帮助我们理解这一切吗?
Cell Death Dis. 2014 May 29;5(5):e1261. doi: 10.1038/cddis.2014.199.
6
Modeling heterogeneous responsiveness of intrinsic apoptosis pathway.模拟内源性凋亡途径的异质性反应。
BMC Syst Biol. 2013 Jul 23;7:65. doi: 10.1186/1752-0509-7-65.
7
Nongenetic origins of cell-to-cell variability in B lymphocyte proliferation.B 淋巴细胞增殖中细胞间变异性的非遗传起源。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2888-E2897. doi: 10.1073/pnas.1715639115. Epub 2018 Mar 7.
8
Stochastic modelling for quantitative description of heterogeneous biological systems.用于定量描述异质生物系统的随机建模。
Nat Rev Genet. 2009 Feb;10(2):122-33. doi: 10.1038/nrg2509.
9
Simulation and inference algorithms for stochastic biochemical reaction networks: from basic concepts to state-of-the-art.随机生化反应网络的模拟与推断算法:从基本概念到最新技术。
J R Soc Interface. 2019 Feb 28;16(151):20180943. doi: 10.1098/rsif.2018.0943.
10
How can we kill cancer cells: Insights from the computational models of apoptosis.我们如何杀死癌细胞:来自细胞凋亡计算模型的见解。
World J Clin Oncol. 2010 Nov 10;1(1):24-8. doi: 10.5306/wjco.v1.i1.24.

引用本文的文献

1
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma.氧化应激增强呼吸抑制剂在 MYC 驱动的淋巴瘤中的治疗作用。
EMBO Mol Med. 2023 Jun 7;15(6):e16910. doi: 10.15252/emmm.202216910. Epub 2023 May 9.
2
A millifluidic study of cell-to-cell heterogeneity in growth-rate and cell-division capability in populations of isogenic cells of Chlamydomonas reinhardtii.莱茵衣藻同基因细胞群体中生长速率和细胞分裂能力的细胞间异质性的微流控研究
PLoS One. 2015 Mar 11;10(3):e0118987. doi: 10.1371/journal.pone.0118987. eCollection 2015.
3
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death.
小分子,大作用:微小RNA在心肌细胞死亡调控中的作用
Cell Death Dis. 2014 Jul 17;5(7):e1325. doi: 10.1038/cddis.2014.287.
4
Monte carlo study elucidates the type 1/type 2 choice in apoptotic death signaling in healthy and cancer cells.蒙特卡罗研究阐明了健康细胞和癌细胞中凋亡死亡信号的 1 型/2 型选择。
Cells. 2013 May 30;2(2):361-92. doi: 10.3390/cells2020361.
5
Death ligand concentration and the membrane proximal signaling module regulate the type 1/type 2 choice in apoptotic death signaling.死亡配体浓度和膜近端信号模块调控凋亡死亡信号中的1型/2型选择。
Syst Synth Biol. 2014 Mar;8(1):83-97. doi: 10.1007/s11693-013-9124-4. Epub 2013 Sep 19.
6
Multivariate analysis of apoptotic markers versus cell cycle phase in living human cancer cells by microfluidic cytometry.通过微流控细胞术对活的人类癌细胞中凋亡标志物与细胞周期阶段进行多变量分析。
Proc SPIE Int Soc Opt Eng. 2013 Mar 9;8615. doi: 10.1117/12.2001474.
7
Spatio-temporal analysis of tamoxifen-induced bystander effects in breast cancer cells using microfluidics.使用微流控技术分析他莫昔芬诱导乳腺癌细胞旁观者效应的时空特征。
Biomicrofluidics. 2012 Jun 8;6(2):24128-241289. doi: 10.1063/1.4726349. Print 2012 Jun.
8
Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms.色素性视网膜炎:快速神经退行性变受缓慢细胞死亡机制的控制。
Cell Death Dis. 2013 Feb 7;4(2):e488. doi: 10.1038/cddis.2013.12.
9
Real-time cell viability assays using a new anthracycline derivative DRAQ7®.使用新型蒽环类衍生物 DRAQ7®进行实时细胞活力分析。
Cytometry A. 2013 Feb;83(2):227-34. doi: 10.1002/cyto.a.22228. Epub 2012 Nov 16.
10
Cytometry of apoptosis. Historical perspective and new advances.细胞凋亡的细胞计数法:历史回顾与新进展
Exp Oncol. 2012 Oct;34(3):255-62.